Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar;55(1):131-55.
doi: 10.1097/GRF.0b013e318248050d.

Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer

Affiliations
Review

Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer

Leigh G Seamon et al. Clin Obstet Gynecol. 2012 Mar.

Abstract

This chapter reviews some of the sentinel Gynecologic Oncology Group (GOG) ovarian trials, describes their rationale, provides summary tables for reference, and is organized into early ovarian cancer (GOG 1, 7601, 7602, 95, 157, 175, 212), advanced ovarian cancer optimal (2, 25, 52, 104, 114, 158, 172, 182, 178, 212, 252), and suboptimal disease (3, 22, 47, 97, 111, 162, 182, 218, 252, 262).

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

LinkOut - more resources